Zekonyte U - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Mitochondrial targeted meganuclease as a platform to eliminate mutant mtDNA in vivo.

Zekonyte U, Bacman SR, Smith J, Shoop W, Pereira CV, Tomberlin G, Stewart J, Jantz D, Moraes CT. Zekonyte U, et al. Nat Commun. 2021 May 28;12(1):3210. doi: 10.1038/s41467-021-23561-7. Nat Commun. 2021. PMID: 34050192 Free PMC article.

DNA-editing enzymes as potential treatments for heteroplasmic mtDNA diseases.

Zekonyte U, Bacman SR, Moraes CT. Zekonyte U, et al. J Intern Med. 2020 Jun;287(6):685-697. doi: 10.1111/joim.13055. Epub 2020 Apr 27. J Intern Med. 2020. PMID: 32176378 Free PMC article. Review.

mitoTev-TALE: a monomeric DNA editing enzyme to reduce mutant mitochondrial DNA levels.

Pereira CV, Bacman SR, Arguello T, Zekonyte U, Williams SL, Edgell DR, Moraes CT. Pereira CV, et al. Among authors: zekonyte u. EMBO Mol Med. 2018 Sep;10(9):e8084. doi: 10.15252/emmm.201708084. EMBO Mol Med. 2018. PMID: 30012581 Free PMC article.

Interlocus gene conversion events introduce deleterious mutations into at least 1% of human genes associated with inherited disease.

Casola C, Zekonyte U, Phillips AD, Cooper DN, Hahn MW. Casola C, et al. Among authors: zekonyte u. Genome Res. 2012 Mar;22(3):429-35. doi: 10.1101/gr.127738.111. Epub 2011 Nov 16. Genome Res. 2012. PMID: 22090377 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4 results

Search Page

Filters